This summary was created by AI, based on 3 opinions in the last 12 months.
Levi Strauss & Co. recently reported a minor sales miss but managed a strong earnings beat, while cutting their full-year revenue forecast. The company's performance varied across different regions, with Europe and direct-to-consumer sales showing strength, but weakness noted in Asia and America. Despite a slight revenue miss, a significant earnings beat was reported, with shares also demonstrating a strong performance in the past year. Additionally, there are potential opportunities for the company in the weight-loss drug industry, although the recent weak quarter and cut in guidance have raised concerns.
They just reported a minor sales miss but an earnings beat and cut their full-year revenue forecast though asserted their earnings would meet the midpoint of previous guidance. Europe and direct-to-consumer are strong, but Asian and America are weaker.
They just reported a slight revenue, but a strong earnings beat but didn't adjust their guidance. Shares are up 40% this year.
Could benefit from the weight-loss drug boom, because those who take those drugs will need need jeans. But the company reported a weak quarter and cut guidance.
Today, it reported an earnings and sales beat, but shares fell 16%. They lowered their full-year gross margin outlook a lot, but didn't touch earnings guidance. Also, they forecast a sales decline around 8-12% this quarter.
Levi Strauss & Co. is a American stock, trading under the symbol LEVI-N on the New York Stock Exchange (LEVI). It is usually referred to as NYSE:LEVI or LEVI-N
In the last year, 2 stock analysts published opinions about LEVI-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Levi Strauss & Co..
Levi Strauss & Co. was recommended as a Top Pick by on . Read the latest stock experts ratings for Levi Strauss & Co..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Levi Strauss & Co. In the last year. It is a trending stock that is worth watching.
On 2024-12-06, Levi Strauss & Co. (LEVI-N) stock closed at a price of $17.77.